Hovione and Particle Sciences Inc (PSI) have entered a collaboration to combine their technologies in an effort to speed development projects targeting poorly water-soluble drugs. The two companies will use their solid solution technologies based on spray-drying capabilities to target ways of maximizing the bioavailability of BCS Class II APIs. PSI will develop the solubilization process and resulting drug product and Hovione will manage the scale-up and industrialization of the spray drying pro...